Novel Therapeutic Agents Provide Hope for Patients with Hard-to-Treat Blood Disorders

Ongoing discoveries of critical molecular markers, pathways, and other drivers of some of the most difficult-to-treat forms of blood cancer have provided unprecedented opportunities for the development of new targeted therapies that attack, block, and silence the deadly genetic mutations that cause these disorders.

http://www.sys-con.com/node/2476727